For years, Los Altos resident Kim Wilford watched Alzheimer’s Disease rob her beloved mother-in-law of her memories, spirit ...
1hon MSN
Neuroscientists develop human brain-wave technology that can accelerate understanding of Alzheimer's
Houston Methodist neuroscientists have developed a first-of-its-kind method to rapidly produce synchronized, human brain wave ...
News-Medical.Net on MSN
UCI MIND secures major funding for new Alzheimer's research facility
With a $50 million lead gift from the Quilter family and approximately $30 million in new commitments, the University of ...
Brittany Butts understands that for many families, Alzheimer's comes as a double burden. As a teenager, she watched not only ...
For additional winter safety tips, click here. The Alzheimer’s Association offers a 24/7 helpline at (800) 272.3900 for free, confidential support, including guidance on safety planning. The West ...
A new study suggests the shingles vaccine may lower the likelihood of developing dementia as well as slow its progression in ...
New findings show that removing Centaurin-α1, a protein elevated in Alzheimer’s disease, significantly reduces inflammation, plaque buildup, and cognitive deficits in a well-established mouse model.
Immediate neuro-rehabilitative treatment following moderate or severe TBI is associated with reduced risk of Alzheimer disease.
Impaired kidney function is associated with increased circulating levels of most Alzheimer disease blood biomarkers.
High levels of calcium are toxic to cells and contribute to loss of neurons in Alzheimer’s disease. Researchers found that a ...
MedPage Today on MSN
Year in Review: Alzheimer's Disease
News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers reported 3-year outcomes for both anti-amyloid drugs, lecanemab (Leqembi) and ...
MedPage Today on MSN
Alzheimer's Benefits May Continue After Donanemab Treatment Ends, Data Suggest
Early Alzheimer's patients who completed their course of donanemab therapy by 12 months had cognitive and functional benefits lasting for 2 additional years, reported Jennifer Zimmer, MD, of Eli Lilly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results